VanEck Pharmaceutical ETF
58 hedge funds and large institutions have $155M invested in VanEck Pharmaceutical ETF in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less capital invested
Capital invested by funds: $225M → $155M (-$70.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $448K
Holders
58
Holding in Top 10
–
Calls
–
Puts
$448K
Top Buyers
| 1 | +$12.4M | |
| 2 | +$4.35M | |
| 3 | +$3.48M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.56M |
| 5 |
Goldman Sachs
New York
|
+$851K |
Top Sellers
| 1 | -$59.1M | |
| 2 | -$3.37M | |
| 3 | -$2.85M | |
| 4 |
SB
Suntrust Banks
Atlanta,
Georgia
|
-$1.69M |
| 5 |
MIM
Macroview Investment Management
Bethesda,
Maryland
|
-$1.55M |